At the March committee meeting, Kinsley said the cost to the state for GLP-1 coverage would be "is in the range of zero to 10 million in state dollars, which is much cheaper than a lot of the costs of cardiovascular disease." According to the NCDHHS statement, which was issued to WUNC on Thursday, "...the current estimate to cover GLP-1s is approximately $16 million annually
A 2024 review describes the connection between GLP1 medications, delayed gastric emptying (including gastroparesis), and increased risk of aspiration during anesthesia, as well as possible effects on the absorption of other medications
Strategic timing gives your body the best chance to adjust gracefully
Saxenda has been associated with an increased risk of gallstones and cholecystitis
Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients
Improved Detoxification : Enhanced support for liver health and toxin elimination